2025 CBD Chronic Pain Epilepsy 
Otherside Farms
NOVEMBER 13, 2019
The CBD business is growing at an alarming rate and with good reason. In actuality, experts project that the industry will be worth sixteen billion dollars by the end of 2025. However, why is the dependency rate on CBD and related compounds increasing by the minute? Cannabidiol Alleviates Chronic Pain.
Cannabis Law Report
SEPTEMBER 13, 2021
Commenting on the size and scope of the market for delaying aging, Dr. Chapman added, “There are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 1 according to a major investment bank. For more information, visit www.mymd.com.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 5, 2022
3 MyMD believes that there are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 according to a major investment bank. MyMD also holds three patents for its synthetic cannabidiol (CBD) derivative Supera-CBD.
Cannabis Law Report
NOVEMBER 16, 2021
The market for treating aging disorders and extending healthy lifespan is expected to be at least $600 billion by 2025 1 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com.
Cannabis Law Report
OCTOBER 20, 2019
For example, there is a growing body of evidence that marijuana is working for chronic pain. Whether or not the pharmaceutical industry can produce a substance they can call a drug that would be approved for a pain indication remains the question,” [xiv]. billion in federal tax revenue between 2017 and 2025. xv] [link].
Cannabis Law Report
FEBRUARY 18, 2020
Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. Non-medical CBD -high products that contain less than 0.3%
Cannabis Law Report
SEPTEMBER 10, 2019
Series A in major European CBD gambit. British medical marijuana and CBD company Cannaray has just closed a £7.8 Cannabidiol, known as CBD, is a key chemical present in plants like cannabis and hemp. Don’t confuse CBD with THC! billion by the end of 2025, according to a report released by Grand View Research, Inc.
Expert insights. Personalized for you.
53 
Let's personalize your content